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Abstract
Objective: To compare quantitative OCT angiography (OCTA) parameters of macular ischemia 
in diabetic eyes without retinopathy with those in healthy nondiabetic controls.
Design: Cross-sectional study from August 2014 through June 2017.
Subjects: Thirty-nine eyes of 39 diabetic patients without clinical evidence of diabetic 
retinopathy and 40 eyes of 40 healthy nondiabetic subjects.
Methods: Subjects underwent OCTA imaging using prototype AngioVue software (RTVue XR 
Avanti). Analyses of the foveal avascular zone (FAZ) and vasculature surrounding the FAZ were 
performed on the automatically generated en face OCTA images of the superficial and deep retinal 
vasculatures using vessel-based and FAZ-based metrics.
Main Outcome Measures: Comparison of measurements made in the superficial and deep 
retinal capillary plexuses of diabetic eyes and normal eyes.
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Results: FAZ-based analysis revealed statistically significant differences between diabetic and 
normal eyes in FAZ area (superficial and deep layers), perimeter (superficial layer), major axis 
length (superficial layer), and minor axis layer (superficial and deep layers). Vessel-based analysis 
revealed statistically significant differences in the binarized flow index (superficial and deep 
layers), both including and excluding the FAZ area.
Conclusions: Quantitative OCTA parameters reveal subclinical macular ischemia at both the 
superficial and deep retinal capillary plexuses in diabetic eyes that do not manifest clinical 
retinopathy. Vessel-based and FAZ-based metrics applied to OCTA images may serve as effective 
tools for screening and disease monitoring in patients with diabetes without clinical evidence of 
retinopathy.
Diabetic retinopathy is the most common cause of visual impairment among working-age 
adults in the developed world.1 The current gold standard for detection of diabetic 
retinopathy is a dilated fundus examination. In addition, fluorescein angiography (FA) is 
used to evaluate the retinal vasculature in diabetic eye disease. FA has high sensitivity for 
detecting microaneurysms and areas of neovascularization, and it may be helpful to visualize 
retinal vascular changes in diabetic eyes that are otherwise not visible on examination.2 
However, FA has several limitations, including an inability to independently visualize the 
deep retinal capillary plexus, increased cost and length of study time, and possible adverse 
effects due to dye injection, such as nausea, vomiting, and, rarely, allergic reactions.3
In contrast, OCT angiography (OCTA) is a noninvasive imaging modality based on depth-
resolved motion-contrast imaging that operates by comparing the fluctuations in signal 
amplitude due to movement of blood cells relative to the static surrounding tissue. By 
enhancing fluctuations in OCT signal among sequential B-scans acquired at a given retinal 
location, a 3-dimensional OCT angiogram is generated. This allows assessment of the retinal 
and choroidal microvasculature in a noninvasive fashion.4,5 A unique property of OCTA in 
comparison to dye-based angiography is that it is depth-resolved, enabling the generation of 
3-dimensional angiograms that can be used to analyze the retinal and choroidal capillary 
plexuses at varying depths. Because imaging the deep retinal capillary plexus is not 
currently possible using current FA techniques, many recent insights into microvascular 
diseases of the retina and choroid have been achieved using OCTA.
Over the past several years, a number of research groups have used OCTA to study the 
microvascular changes that occur in patients with diabetic retinopathy. OCTA has previously 
been used to qualitatively describe features such as an enlarged foveal avascular zone (FAZ), 
areas of ischemia, microaneurysms, and neovascularization in eyes with diabetic retinopathy.
4,6–9
 Quantitative studies analyzing the retinal microvasculature using automated algorithms 
applied to OCTA have described reduced vessel density in eyes with diabetic retinopathy.
10–13
Recent evidence suggests that microvascular changes such as enlargement and/or 
remodeling of FAZ and areas of capillary nonperfusion may begin before diabetic 
retinopathy is clinically evident.14,15 This study aims to compare quantitative OCTA 
parameters of macular ischemia in diabetic eyes without retinopathy with those in healthy 
nondiabetic controls.
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Methods
Subjects
Diabetic patients without clinical evidence of retinopathy and healthy nondiabetic controls 
were imaged using the prototype OCTA software on a commercially available Avanti 
spectral-domain (SD) OCT system (Optovue, Fremont, CA) at the New England Eye Center 
between August 2014 and June 2017. This study was approved by the institutional review 
board of Tufts Medical Center and adhered to the Declaration of Helsinki and the Health 
Insurance Portability and Accountability Act of 1996. Informed consent was obtained from 
all subjects in accordance with the Tufts Medical Center institutional review board before 
enrollment in the study. All OCTA images were de-identified before being placed in a 
database of OCTA images at the New England Eye Center.
The diagnosis of diabetes without clinical retinopathy was made by a retina specialist based 
on a complete ophthalmic examination, including dilated fundus examination with slit-lamp 
biomicroscopy and indirect ophthalmoscopy and, in selected cases, structural OCT imaging 
on commercially available SD-OCT (Carl Zeiss Meditec Inc, Dublin, CA; software version 
6.0) and FA (Heidelberg Spectralis, Spectralis HRA + OCT, Heidelberg Engineering Inc, 
Heidelberg, Germany). Diabetic patients with any previous or concomitant posterior 
segment pathologies such as diabetic retinopathy of any severity, age-related macular 
degeneration, retinal detachment, and vascular occlusions, and those with a myopic 
refractive error of ≥6 diopters, were excluded. The healthy nondiabetic control subjects had 
a best-corrected visual acuity of 20/20 or better and underwent a dilated fundus examination 
to exclude any pre-existing posterior segment pathology.
OCT Angiography Imaging
All subjects underwent OCTA imaging using prototype AngioVue software within the 
RTVue XR Avanti SD-OCT device (Optovue, Inc, Fremont, CA) that operates at a 
wavelength of 840 nm, a bandwidth of 45 nm, and a speed of 70 000 A-scans per second. 
Volumes, 3 × 3 mm in area and centered at the fovea, consisted of 304 A-scans per B-scan 
and 304 B-scan locations per volume; 2 repeated B-scans were acquired at each B-scan 
position to allow for OCTA. Split-spectrum amplitude-decorrelation angiography16 was used 
to generate OCTA images. All OCTA imaging was performed by trained ophthalmic 
photographers who repeated imaging several times, if necessary, to ensure acquisition of the 
best image quality. This is consistent with the standard imaging protocol at the New England 
Eye Center.
Quantification of Retinal Vasculature
Analyses of the FAZ and vasculature surrounding the FAZ were performed on the 
automatically generated en face OCTA images of the superficial and deep retinal 
vasculatures. All analysis was performed using MATLAB (MathWorks, Natick, MA). 
Before quantification of vascular features, the scan-logo in the bottom left of the images (red 
arrow in Fig 1A) was excluded from the analysis. The processing steps involved in the 
analyses are schematically outlined in Figure 1. The methodology of quantification is 
described below.
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Foveal Avascular Zone–Based Analysis.—FAZ areas on the superficial and deep 
images were manually traced by a masked reader using a custom MATLAB application. For 
the FAZ-based analysis, we evaluated the following metrics:
FAZ Area [mm2]: area within the traced FAZ
FAZ Perimeter [mm]: length of the contour demarcating the FAZ
Acircularity Index (AI): ratio of the FAZ perimeter to the perimeter of a circle with an area 
equal to that of the FAZ–mathematically, AI = Perimeter/√(4 × π × Area)17
Major Axis Length [mm]: major axis of the ellipse that has the same normalized second 
central moments as the region
Minor Axis Length [mm]: minor axis of the ellipse that has the same normalized second 
central moments as the region
Axis Ratio: ratio of the major axis length to the minor axis length.17
Vessel-Based Analysis.—The following vessel-based metrics were evaluated, both with 
the FAZ excluded and with the FAZ included:
Mean Signal Index: defined as the mean OCTA signal over the image field-of-view. For the 
analysis with the FAZ excluded, the mean was taken over the image pixels outside the FAZ 
boundary.
Binarized Flow Index (BFI): defined similarly to the flow index described by Jia et al.18 
Computation of the BFI proceeds in 3 steps: (1) Image binarization (Fig 1C). The threshold 
used for binarization is set at 3 standard deviations above the mean noise level in the FAZ. 
Artifacts causing bright OCTA signals within the FAZ were excluded from the noise 
analysis. (2) Spatial averaging of the binarized image via convolution with a disk structuring 
element (kernel) having a 250-μm diameter. (3) Averaging of the output from (2). For the 
analysis with the FAZ excluded, the mean was taken over the image pixels outside the FAZ 
boundary.
Capillary Perfusion Density (CPD): defined analogously to Agemy et al.13 Computation of 
the CPD proceeds in 4 steps: (1) Binarization, as described for the BFI. (2) Skeletonization 
of the binarized image (Fig 1D). (3) Spatial averaging, as described for the BFI. (4) 
Averaging of the output from (3), as described for the BFI.
The spatially averaged BFI and CPD were semi-transparently overlaid on the binarized, 
skeletonized, or original OCTA images (Fig 2A.2 and B.2; Fig 3A.2 and B.2). The BFI and 
CPD metrics were also analyzed as a function of distance from the FAZ margin as follows:
Radial Vascular Maps: These maps show the dependency of a given vessel metric as a 
function from the FAZ boundary. Computation proceeds in 3 steps: (1) Every pixel outside 
the FAZ is assigned a distance from the FAZ, defined as the distance between that pixel and 
the closest point on the FAZ boundary. (2) Using these distances, the image is divided into 
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radial sectors, where a given sector contains all pixels whose distance from the FAZ lies 
within a given range (for this study, we used 250-μm sectors; Fig 1E). (3) Averaging of the 
vessel metric over each sector (Fig 1F).
Statistical Analysis
The en face OCTA of the superficial and deep retinal capillary plexuses were analyzed as 
independent datasets. For all metrics, the control and diabetic groups were compared using 
the Mann–Whitney U test, with significance set at 0.05. Pearson correlation coefficient was 
used to check for correlations of the metric values with age and signal strength. All analysis 
was performed using MATLAB.
Results
A total of 39 eyes of 39 patients with diabetes without clinical retinopathy and 40 eyes of 40 
healthy nondiabetic control subjects were imaged using OCTA. Mean HbA1c was 7.1 and 
mean visual acuity was 20/30 in the diabetic group. The mean age of the diabetic patients 
was 54±10.7 years and that of the healthy subjects was 48±17.8 years (P = 0.089, Mann–
Whitney U). The mean OCT signal strengths were 72.9±6.4 and 71.7±4.9 for the control and 
diabetic groups, respectively (P = 0.26, Mann–Whitney U; all signal strengths were >60).
The results of the FAZ-based analysis are summarized in Table 1, and those of the vessel-
based analysis are summarized in Table 2. Examples of analyzed images are shown in 
Figures 2 and 3. Histogram plots of the FAZ areas and BFI are shown in Figure 4.
Discussion
In this study, both FAZ-based and vessel-based metrics were used to identify macular 
ischemia in diabetic eyes without clinical retinopathy and in healthy nondiabetic control 
eyes. Vessel-based metrics were evaluated in 3 ways: (1) globally, both including and 
excluding the FAZ; (2) locally (and qualitatively), using spatial averaging; and radially, by 
averaging metrics over sectors lying different distances away from the FAZ margin.
The FAZ-based analysis revealed statistically significant differences in the FAZ area 
(superficial and deep layers), perimeter (superficial layer), major axis length (superficial 
layer), and minor axis layer (superficial and deep layers). The observations of increased FAZ 
area in diabetic subjects, compared with controls, agrees with previous literature.14,15,19–22 
We suspect that an obfuscation of detail in the OCTA images of the deep layer, which causes 
the FAZ to appear more circular in shape, may have contributed to the finding that the 
perimeter and major axis lengths were found to be significantly higher in the superficial 
layers but not in the deep layers. It should be noted that although both the major and minor 
axis lengths tended to be longer in diabetic patients, the ratio of these 2 was not found to be 
statistically different from that in controls, which is consistent with previous studies.17 The 
observation that the AI in controls did not differ from that in diabetic patients in a 
statistically significant way is also consistent with prior results.17 Interestingly, although not 
statistically significant, the AI in the deep layer was lower in diabetic patients than in 
controls. Again, this may be attributable, in part, to the observation that in the deep layer, 
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and in diabetic subjects in particular, OCTA images of the FAZ are less defined, making the 
FAZ appear more circular in shape.
The vessel-based analysis revealed statistically significant differences in the BFI (superficial 
and deep), both including and excluding the FAZ area. Analysis of the BFI as a function of 
distance from the FAZ margin revealed that the most significant differences between the 2 
groups occurred from 500 μm away from the FAZ margin and outward (Fig 5). To our 
knowledge, this is the first report of such analysis, and future studies to better understand 
this finding are merited. Although not statistically significant, the mean signal index and 
CPD were also reduced in diabetic patients as compared with controls. The lack of a 
difference in CPD at either the superficial or deep retinal capillary plexus is somewhat at 
odds with recent publications.21 Dimitrova et al21 calculated parafoveal vessel density in the 
superficial and deep plexuses using a circle of 1.25 mm radius, centered at the fovea, and 
excluded the central area within a circle of 0.3 mm radius. The enlarged FAZ area that they 
reported would have expanded beyond the boundaries of this inner circle and may have 
impacted their parafoveal vessel density measurements. In our study, in which we excluded 
the entire, manually traced FAZ area from our CPD measurements, we failed to find a 
statistical significance in CPD between controls and diabetic patients.
Comparing FAZ-based and vessel-based metrics, we believe that each class of techniques 
has its advantages and disadvantages. FAZ measurements are relatively easy to perform 
manually and are relatively robust to noise and image quality. That being said, FAZ 
measurements are highly dependent on accurate layer segmentation, particularly when the 
deep and superficial layers are separated; accurate layer segmentation is especially 
challenging in patients with pathology. Furthermore, it has been our observation that the 
details of the FAZ boundary are less obvious in the deep layer than in the superficial layer. 
Compared with FAZ tracing, manual extraction of retinal vasculature is not feasible, making 
automated analysis a necessity. Most vessel-based metrics require, as a first step, 
binarization of the OCTA image. Binarization, though conceptually simple, is a complex 
problem that can be influenced by many factors, including signal levels, noise levels, optical 
focusing, vascular density, and motion artifacts (red arrows of Fig 2B.1 and B.2). If the 
threshold used for binarization is too high, true vasculature will be removed; if the threshold 
is too low, noise will masquerade as vasculature. There is also the question of whether a 
single, global threshold should be used or whether local (spatially adaptive) thresholding 
should be used; similarly, there is a question of whether a single threshold should be used for 
all images or whether the threshold should be adapted on a per-image basis, as was done in 
this study. Unfortunately, in making these processing decisions, there is usually no clear 
answer, and different choices may result in drastically different results. Nevertheless, 
compared with FAZ measurements, vessel-based techniques may, with improved image 
quality and analysis techniques, provide more sensitive and/or comprehensive information 
regarding diseases status.
Another consideration in comparing FAZ-based and vessel-based metrics is their 
dependency on age. Previous studies have found that vessel density–related measures 
decrease with age, which is consistent with the findings of this study (Fig 6).23,24 In 
contrast, we did not observe a correlation between FAZ area and age (Fig 6). That the FAZ 
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area appears largely decoupled from age simplifies its interpretation in cohorts of subjects of 
varying age. Overall, at the time of writing, it is the authors’ belief that, at least for the 
purposes of robustly detecting diabetes-related vascular alterations in diabetic subjects 
without retinopathy, FAZ measurements, and in particular the FAZ area, serve as the more 
robust metric. Whether FAZ enlargement is the first detectable change in the eyes of diabetic 
patients remains an open question.
This study is limited in that it is retrospective in design and involves a small sample size. 
Future longitudinal studies involving a large sample size may help to further determine the 
utility of automated measures of macular ischemia in diabetic eyes. There are also 
limitations related to the OCTA acquisition and signal processing steps in this study. As with 
most OCTA-based analysis, results are dependent on the quality of the inputted image. In 
particular, it is plausible that decreases in signal strengths may cause changes in FAZ-based 
and vessel-based metrics, for instance due to thresholding or binarization errors.25,26 Our 
analysis (Fig 7) of signal strength showed that FAZ area measurements were very weakly 
correlated with signal strength values, whereas BFI was more strongly correlated, 
particularly in normal subjects. Overall, there was no statistically significant difference in 
signal strengths between the control and diabetic groups, and all signal strengths were >60. 
Another processing-related limitation of this study, again shared by most OCTA studies, is 
the possibility of incorrect layer segmentation. As noted previously, errors in segmentation 
will cause errors in both FAZ-based and vessel-based analysis. Although all layer 
segmentations used in this study were the default contours automatically computed by the 
Optovue software, images with obviously incorrect segmentations were excluded. 
Furthermore, as this study was done on normal controls and diabetic patients without 
diabetic retinopathy, the absence of pathology somewhat limits the severity of this limitation.
In conclusion, methods for quantifying macular ischemia presented in this study have 
provided further evidence of subclinical manifestations of diabetic retinopathy. These 
methods may potentially serve as effective tools for screening and disease monitoring. 
However, larger-scale studies are needed to confirm our results.
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Figure 1. 
Summary of processing steps used in analysis. Yellow arrows indicate the workflow; 
squiggly arrows indicate that the listed metrics are derived from that processing step. A, 
Input image; red arrow points to the scan-logo, which is removed from the analysis. B, 
Segmented foveal avascular zone (FAZ); red contour indicates FAZ boundary. This contour 
is used to derive the FAZ-based metrics. It is also used for computation of all metrics in 
which the FAZ is excluded. C, Binarized image. D, Skeletonized image. E, Level sets (bold 
white) of the closest-point-to-FAZ-contour function; the FAZ, in the center, is shown as a 
thin white contour. The level set contours are spaced by 250 μm. F, Radially averaged 
binarized flow index, using the contours from (E), overlaid on the binarized image.
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Figure 2. 
Example analysis on the superficial vasculature for A, a 66-year-old control, and B, a 66-
year-old diabetic patient. A.1 and B.1, Input OCTA images. A.2 and B.2, binarized flow 
index (BFI) overlaid on the binarized OCT angiography (OCTA) images (red corresponds to 
higher flow index and blue to lower flow index). The red arrows point to motion artifacts, 
which, while somewhat hidden in the input OCTA image, appear as thresholded regions in 
the binarized image; motion artifacts present a substantial challenge to vessel-based analysis 
techniques. A.3 and B.3, Radially averaged BFI overlaid on the binarized OCTA images 
(with the same color scale as in A.2 and B.2).
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Figure 3. 
Example analysis on the deep vasculature for the same patients as in Figure 2. (See caption 
of Figure 2 for figure description.) The red arrows point to a superficial retinal vessel 
appearing within the deep vasculature because of a projection image. This sort of artifact can 
confound quantitative vessel-based analysis of the deeper vasculature.
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Figure 4. 
Histograms of the foveal avascular zone (FAZ) area (top row) and binarized flow index 
(bottom row); the left column corresponds to the superficial vasculature and the right 
column corresponds to the deep vasculature.
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Figure 5. 
Bar plots of the binarized flow index as a function of the distance from the foveal avascular 
zone (FAZ) margin. Labels on the x-axis indicate the sector boundaries; i.e., (0, 0.25] 
denotes a sector starting at, but not including, the FAZ margin, and ending at, and including, 
the level set contour 0.25 mm away from the FAZ margin. The numbers above the brackets 
correspond to P values (black text corresponds to P values for the superficial layer; gray text 
corresponds to P values for the deep layer).
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Figure 6. 
Scatter plots of the foveal avascular zone (FAZ) area (first row) and binarized flow index 
(second row) as a function of age; the first column corresponds to the superficial layer and 
the second column to the deep layer. Linear regression lines are shown as dashed lines. Blue 
points and lines correspond to controls; red points and lines correspond to diabetic patients. 
Pearson correlation coefficients for the controls and diabetic patients are listed in blue and 
red text, respectively.
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Figure 7. 
Scatter plots of the foveal avascular zone (FAZ) area (first row) and binarized flow index 
(second row) as a function of signal strength; the first column corresponds to the superficial 
layer and the second column to the deep layer. Linear regression lines are shown as dashed 
lines. Blue points and lines correspond to controls; red points and lines correspond to 
diabetic patients. Pearson correlation coefficients for the controls and diabetic patients are 
listed in blue and red text, respectively. a.u. = arbitrary unit.
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